Background and objectives: Growth failure is common among children with
congenital heart disease (CHD). This study aimed at the assessment of the effect of
therapeutic cardiac catheterization on the growth status of children with CHD.
Patients and Method: This was a prospective observational study conducted at
pediatric cardiac catheterization unit-Sohag university hospital, from October-2016 to
September-2017, on children with congenital acyanotic heart diseases who were
admitted for therapeutic cardiac catheterization. We assessed the growth parameters
as a weight for age Z-score (WAZ), height for age Z-score (HAZ), body mass index
and upper arm circumference before catheterization, at one month, three months and
six months after catheterization. The growth status was considered normal when WAZ
and HAZ were from < +2 SD to > -2 SD, underweight if WAZ was ≤ -2 SD and
stunting if HAZ was ≤ -2 SD.
Results: One-hundred and two children with congenital acyanotic heart diseases were
included. The mean age was 3.95 ±3.11 years. Sixty participants(58.8%) were
females. Before catheterization,70 patients (68.6%) had normal growth status, 20
patients (19.6%) had underweight and 19 patients (18.6%) had stunting. The
prevalence of underweight significantly diminished to3.92% (p < 0.001) at the 6th
month after catheterization. However, no significant differences in the prevalence of
stunting were found during the follow-up period.
Conclusion: Therapeutic cardiac catheterization had a significantly positive impact
on weight gain shortly after catheterization. However, improvement in the height
could not be detected in the first 6 months after catheterization and longer follow-up
periods are required.